References
- Chertkow H, Feldman HH, Jacova C, et al. Definitions of dementia and predementia states in Alzheimer’s disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia. Alzheimer’s Res Ther. 2013;5(1):S2.
- Ritchie CW, Russ TC, Banerjee S, et al. The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease. Alzheimer’s Res Ther. 2017;9(1):85.
- Ryan NS, Rossor MN, Fox NC. Alzheimer’s disease in the 100 years since Alzheimer’s death. Brain. 2015;138(12):3816–3821.
- Alzheimer A, Stelzmann RA, Schnitzlein HN, et al. An english translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clin Anat. 1995;8(6):429–431.
- de la Rubia Orti JE, Garcia-Pardo MP, Drehmer E, et al. Improvement of main cognitive functions in patients with Alzheimer’s disease after treatment with coconut oil enriched mediterranean diet: a pilot study. J Alzheimers Dis. 2018;65(2):577–587.
- Canhada S, Castro K, Perry IS, et al. Omega-3 fatty acids’ supplementation in Alzheimer’s disease: a systematic review. Nutr Neurosci. 2018 Oct;21(8):529–538.
- Yang X, Zhang Y, Xu H, et al. Neuroprotection of coenzyme Q10 in neurodegenerative diseases. Curr Top Med Chem. 2016;16(8):858–866.
- Marcason W. What is the lowdown on coral calcium? J Acad Nutr Diet. 2003;103(10):1319.
- Zhang M, Schmitt-Ulms G, Sato C, et al. Drug repositioning for Alzheimer’s disease based on systematic ‘omics’ data mining. PLoS One. 2016;11(12):e0168812.
- Lleó A. Current therapeutic options for Alzheimer’s disease. Curr Genomics. 2007;8(8):550–558.
- Hu J, Liu Z-S, Tang S-L, et al. Effect of hydroxyapatite nanoparticles on the growth and p53/c-Myc protein expression of implanted hepatic VX2 tumor in rabbits by intravenous injection. World J Gastroenterol. 2007;13(20):2798.
- Chen X, Deng C, Tang S, et al. Mitochondria-dependent apoptosis induced by nanoscale hydroxyapatite in human gastric cancer SGC-7901 cells. Biol Pharm Bull. 2007;30(1):128–132.
- Yen K-C, Chen I-H, Lin F-H. Preparation of calcium phosphate nanoparticles as non-viral vectors for gene delivery system. Biomed Eng Appl Basis Commun. 2017;29(4):1750027.
- Chang K-C, Li C-Y, Hsu C-K, et al. Synthesis and properties of Fe-modified calcium-deficient hydroxyapatite nanocrystal for MRI contrast agent. Biomed Eng Appl Basis Commun. 2011;23(5):393–401.
- Wu H-C, Lin F-H. Evaluation of magnetic-hydroxyapatite nanoparticles for gene delivery carrier. Biomed Eng Appl Basis Commun. 2010;22(1):33–39.
- Matsumoto T, Okazaki M, Nakahira A, et al. Modification of apatite materials for bone tissue engineering and drug delivery carriers. Curr Med Chem. 2007;14(25):2726–2733.
- Zhang N, Gordon ML. Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients. Clin Interv Aging. 2018;13:1963–1970.
- Lim GK, Wang J, Ng SC, et al. Processing of hydroxyapatite via microemulsion and emulsion routes. Biomaterials. 1997 Nov;18(21):1433–1439.
- Murray MGS, Wang J, Ponton CB, et al. An improvement in processing of hydroxyapatite ceramics. J Mater Sci. 1995 Jun 15;30(12):3061–3074.
- Zhou WY, Wang M, Cheung WL, et al. Synthesis of carbonated hydroxyapatite nanospheres through nanoemulsion. J Mater Sci-Mater M. 2008 Jan;19(1):103–110.
- Pradeesh TS, Sunny MC, Varma HK, et al. Preparation of microstructured hydroxyapatite microspheres using oil in water emulsions. B Mater Sci. 2005 Aug;28(5):383–390.
- Coats A, Redfern J. Thermogravimetric analysis. A review. Analyst. 1963;88(1053):906–924.
- Elati CR, Vankawala PJ, Chalamala SR, et al. Polymorphic study of donepezil hydrobromide. 2005.
- Shin CY, Kim HS, Cha KH, et al. The effects of donepezil, an acetylcholinesterase inhibitor, on impaired learning and memory in rodents. Biomol Ther (Seoul). 2018 May 1;26(3):274–281.
- Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848.
- Chuong MC, Kelley CJ, Muhammad Y, et al. Investigating effect of water of hydration on active pharmaceutical ingredients in a water-sensitive dosage form. J Anal Sci Technol. 2018;9(1):7.
- Brundavanam RK, Poinern GEJ, Fawcett D. Modelling the crystal structure of a 30 nm sized particle based hydroxyapatite powder synthesised under the influence of ultrasound irradiation from X-ray powder diffraction data. Am J Mater Sci. 2013;3(4):84–90.
- Arsad MS, Lee PM, Hung LK, editors. Synthesis and characterization of hydroxyapatite nanoparticles and β-TCP particles. 2nd International Conference on Biotechnology and Food Science IPCBEE; Singapore: IACSIT Press; 2011.
- Venkateswarlu K, Sreekanth D, Sandhyarani M, et al. X-ray peak profile analysis of nanostructured hydroxyapatite and fluorapatite. International Journal of Bioscience, Biochemistry and Bioinformatics. 2012:389–393. DOI:10.7763/IJBBB.2012.V2.139
- Zhang S, Li J, Lykotrafitis G, et al. Size-dependent endocytosis of nanoparticles. Adv Mater. 2009;21:419–424.
- Kou L, Sun J, Zhai Y, et al. The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharm Sci. 2013;8(1):1–10.
- Shyong YJ, Tsai CC, Lin RF, et al. Insulin-loaded hydroxyapatite combined with macrophage activity to deliver insulin for diabetes mellitus. J Mater Chem B. 2015 Mar 21;3(11):2331–2340.
- Shyong Y-J, Wang M-H, Kuo L-W, et al. Mesoporous hydroxyapatite as a carrier of olanzapine for long-acting antidepression treatment in rats with induced depression. J Control Release. 2017;255:62–72.
- Zhou H, Lee J. Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater. 2011 Jul;7(7):2769–2781.
- Swetha M, Sahithi K, Moorthi A, et al. Biocomposites containing natural polymers and hydroxyapatite for bone tissue engineering. Int J Biol Macromol. 2010 July 1;47(1):1–4.
- Oberbek P, Bolek T, Chlanda A, et al. Characterization and influence of hydroxyapatite nanopowders on living cells. Beilstein J Nanotechnol. 2018;9:3079–3094.
- Tao X, Li Y, Hu Q, et al. Preparation and drug release study of novel nanopharmaceuticals with polysorbate 80 surface adsorption. J Nanomater. 2018;2018.
- Uhr M, Grauer MT, Holsboer F. Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biol Psychiatry. 2003;54(8):840–846.
- Cacabelos R. Donepezil in Alzheimer’s disease: from conventional trials to pharmacogenetics. Neuropsychiatr Dis Treat. 2007;3(3):303.